Location: South San Francisco, CA
Discover and connect with the most innovative emerging biotech, device, diagnostic, and digital health startups. Meet and build relationships with investors and potential collaboration partners. Network with a community of peers that support bringing new bioscience discoveries to market.
We’re thrilled to welcome this year’s Pantheon “Emerging Innovator” award winner, FAST 2019 alum and funding success story, Ashley Zehnder, Ph.D. of Fauna Bio, who will kick off this year’s showcase as our keynote speaker!
CLS is proud to showcase our 2022 Fall FAST cohort:
Therapeutic Category
Angeles Therapeutics: CEO, Preet Chaudhary, Next generation cell therapy company CARs in solid tumors.
Acelot: CEO Katie Planey, Small molecule inhibitors of toxic proteins associated with neurodegenerative diseases.
Biomark Onology: CEO, Kate Edson, Developing a platform to further the use of response biomarkers in clinical trials.
Weatherwax Biotechnologies: CEO, Armand Cognetta, Next generation of induced-proximity medicines or molecular glues, unlocking the ability to go after high-value oncology targets.
f5 Therapeutics: CEO, Gary Choy, Developing “First-in-Class” small molecule degraders for oncology and immunology. [Servier Discovery Awardee]
Diagnostics & Translational Markers Category
Tab Diagnostic: CEO, Troy Barring, First portable saliva-based, diabetic monitoring system.
Cell & Gene Therapy Category
CellFiber: CEO Yu Yanagisawa, Cell encapsulation culture technology enabling highly efficient cell manufacturing processes.
miiBio: CEO, Kensho Hayamizu, “Optical switch protein” to enable on-off switching of gene expression activity.
Digital Health Category
Aikomi: CEO Nick Hird, Digital therapy that utilizes AI to realize “person-centered care” that supports people with dementia.
Therapeutics Q&A Panel:
Diagnostics & Digital Health Q&A Panel:
Thank you to our sponsors and partners:
